Sandra Levy
ARTICLES BY THIS AUTHOR
- 7/26/2021
Roundup: Recent generic launches
Taking a look at some of the innovative new generics making their debut: - 7/26/2021
FDA approves new Shingrix indication
Shingrix is now approved for the prevention of shingles in those who are immunocompromised. - 7/26/2021
Rolling with the punches: Generics firms innovate, expand scope to stay competitive
As they continue to navigate pandemic headwinds, generics firms look to broaden their portfolios and vertically integrate to keep competitive. - 7/26/2021
GSK starts shipping influenza vaccines for 2021-2022 season
GSK said it expects to distribute a record supply of more than 50 million doses of its influenza vaccine for the upcoming flu season. - 7/25/2021
Sun Pharma, Cassiopea ink license, supply agreements for Winlevi
Sun Pharma will have the exclusive right to commercialize Winlevi in the United States and Canada, and Cassiopea will be the exclusive supplier of the product. - 7/25/2021
Omnicell to acquire FDS Amplicare for $177M
The FDS Amplicare business that is being acquired had roughly $29 million of total revenue for the 12 months ended June 30. - 7/25/2021
APhA joins 50-plus orgs urging COVID-19 vaccine mandates for all health workers
The endorsement looks to make the healthcare sector a leader in COVID-19 vaccination just as cases, hospitalizations and deaths are once again rising throughout the United States. - 7/25/2021
Nexus debuts potassium chloride in water for injection
Potassium chloride injection is indicated in the treatment of potassium deficiency states when oral replacement is not feasible. - 7/22/2021
Intas, Meiji and Dong-A ST to commercialize Stelara biosimilar
Biosimilar ustekinumab will provide a treatment of autoimmune and inflammatory diseases such as plaque psoriasis, Crohn's disease and ulcerative colitis.
